—
Focus of several industry players on development of effective products and enhancing existing products is expected to favor business growth. Moreover, massive technologies are being introduced to discourse different ecological effect of anesthetic gases and rummage them from hospital vents for further recycling. Introduction of several anesthesia recycling systems by companies such as Anesthetic Gas Reclamation LLC to address the environmental concerns will further foster industry growth. However, patent expiration and side effects of inhalation anesthetics may hinder the overall inhalation anesthesia business growth.Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467773/?utm_source=marketersmedia.com-SP
Inhalation anesthesia market will exceed USD 1.9 billion by 2025; as per a new research report. Inhalation anesthesia market growth is primarily driven by increasing demand for surgeries owing to rise in prevalence of neurological, respiratory and other chronic diseases. Favorable reimbursement scenario in developed economies for various surgical procedures will surge industry demand over the coming years. Rising R&D investments in inhalation anesthesia industry will considerably upsurge the business size. Moreover, availability of various insurance schemes for affordable and quick surgical procedures will foster inhalation anesthesia industry growth during the forecast period.
Sevoflurane segment accounted for more than 70% revenue share in 2018 and will witness similar growth trend over the coming years. Sevoflurane with or without the addition of nitrous oxide is suitable for inhalation or gas induction and is widely preferred in pediatric patients. Advantages of sevoflurane including non-pungent odor, minimum effect on cerebral blood flow and low blood gas solubility will further increase its adoption, thus accelerating the segmental growth.
Asia Pacific inhalation anesthesia industry accounted for more than 20% revenue share in 2018 and is assessed to witness significant CAGR by 2025. Rising adoption of advanced technologies for effective assessment and improved patient care will favor regional market growth. Increasing healthcare spending in the region coupled with growing demand for surgical procedures will spur Asia Pacific market.
Hospitals segment will witness around 5% CAGR during the forecast timeframe. Rising incidence of injuries and surgical procedures will augment segmental growth. Growing number of multispecialty hospital settings to provide corrective treatment for patients will propel business growth. Additionally, cost effective treatment and surgeries provided by different government hospitals in middle-and-low income countries will act as a positive impact rendering factor in the segment growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467773/?utm_source=marketersmedia.com-SP
Induction segment was valued around USD 250 million in 2018. Different factors influencing induction anesthesia segment include Minimum Alveolar Concentration (MAC), rate of metabolism by kidney/liver, patient?s age, potency and therapeutic index of drug among others will positively impact the segment growth. Also, induction of anesthesia necessitates higher concentration of drug than the amount required for maintenance, thereby surging the market.
Some of the notable business players operating in inhalation anesthesia market include Baxter International, Halocarbon Products, Abbvie, Hikma Pharmaceuticals, Piramal, Lunan Pharmaceutical, Fresenius Kabi and Jiangsu Hengrui Medicine. These business players focus on new product launches, mergers, acquisitions and collaborations to maintain their financial stability and sustain market competition. For instance, in May 2016, Piramal partnered with Julphar, a Middle East and Africa based pharmaceutical company for distribution of Sojourn (Sevoflurane) in Saudi Arabia. This partnership enabled company to enhance its geographic reach and broaden customer base.
Table of Content:
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Inhalation anesthesia industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. End-use trends
2.1.5. Regional trends
Chapter 3. Inhalation Anesthesia Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Surge in number of emergency cases
3.3.1.2. Growing demand for surgical procedures worldwide
3.3.1.3. Rising geriatric population susceptible to chronic diseases
3.3.1.4. Advantages of inhalation anesthetics over injectable anesthetics
3.3.2. Industry pitfalls and challenges
3.3.2.1. Side effects associated with anesthetics
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By application
3.4.3. By end-use
3.5. Porter's analysis
3.6. Competitive landscape, 2018
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Inhalation Anesthesia Market, By Product
Chapter 5. Inhalation Anesthesia Market, By Application
Chapter 6. Inhalation anesthesia Market, By End-use
Chapter 7. Inhalation Anesthesia Market, By Region
Chapter 8. Inhalation Anesthesia Market Company Profiles
For more information on this report at: https://www.marketstudyreport.com/reports/inhalation-anesthesia-market/?utm_source=marketersmedia.com-SP
Related Report:
Global (United States, European Union and China) Inhalation Anesthesia Market Research Report 2019-2025
Inhalation anesthetics are used to induce and maintain general anesthesia while performing surgical procedures. Inhalation anesthetic agents are administered through masks or tracheal tubes. These agents get perfused into blood though alveoli and transported to central nervous system where these induce anesthesia. Inhalation anesthesia has an advantage over other intravenous agents and is considered safer by surgeons. Rising adoption of these drugs in major markets such as U.S., Europe, and Japan is expected to drive revenue growth.
https://www.marketstudyreport.com/reports/global-united-states-european-union-and-china-inhalation-anesthesia-market-research-report-2019-2025?utm_source=RR-SP
Read more at: https://www.marketwatch.com/press-release/at-104-cagr-plasma-therapy-market-size-is-expected-to-reach-usd-286-million-by-2024-2019-08-19
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com
Release ID: 88910366
Google
RSS